Clinical TrialsSearch results
Number of results: 265
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Prospective intra-individual comparison of the mpMRI versus 68Ga-PSMA11 PET/MRI in a blinded read to evaluate diagnostic accuracy in patients with prostate cancer
- Prostate Cancer
- Kojima Yoshiyuki
- 2022-09-15
Recruiting
- A Randomized Controlled Trial to Compare The Sedative Efficacy and Safety of Isoflurane and Dexmedemomidine in Patients after Cardiovascular Surgery
- cardiovascular diseases
- Hakozaki Takahiro
- 2022-07-21
Recruiting
- Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Paroxysmal Nocturnal Hemoglobinuria
- Suzuki Kazuyuki
- 2021-12-17
Recruiting
- A study to evaluate the efficacy and safety of rozanolixizumab in adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOG-AD)
- Myelin oligodendrocyte glycoprotein (MOG)antibody-associated disease (MOG-AD)
- MATSUO TETSUO
- 2021-11-24
Recruiting
- Safety study of artificial neural connection in stroke
- Brain infarction, hemorrhage
- Kikuchi Naohisa
- 2021-11-19
Recruiting
- Program of Angiotensin-Neprilysin Inhibition in Admitted Patients with Worsening Heart Failur
- Worsening heart failure with both signs of congestion and symptoms of heart failure
- Node Koichi
- 2021-11-15
Recruiting
- Development of a questionnaire to evaluate the risk of chronic postsurgical pain
- Chronic Pain
- NAKANO YUKO
- 2021-10-29
Recruiting
- Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation
- ASCVD, CKD and systemic inflammation
- Miyazaki Daisuke
- 2021-09-07
Recruiting
- An Exploratory Study of FHM-001 in Patients with Depression
- depression (DSM-5)* (single episode or recurrent)
- Furukawa Toshiaki
- 2021-08-19
Recruiting
- Pivotal study of danicopan as add-on therapy to a C5 inhibitor (eculizumab or ravulizumab) in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) who have Clinically Evident EVH
- Paroxysmal Nocturnal Hemoglobinuria
- Kamata Takeo
- 2021-06-28